Recombinant SARS S1 Protein (aa 1-667) [His] (VAng-Lsx0061)
SARS S1 [His], recombinant protein from . (Accession# AAX16192.1)
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
20 mM Tris, 500 mM NaCl, 10 % glycerol, pH 7.4.
Storage
Store at -20°C to -80°C.
Introduction
Severe acute respiratory syndrome is a viral respiratory disease in humans which is caused by the SARS coronavirus (SARS-CoV). Between November 2002 and July 2003, an outbreak of SARS in Hong Kong nearly became a pandemic, with 8, 422 cases and 916 deaths worldwide (10.9 % fatality) according to the World Health Organization. Within weeks, SARS spread from Hong Kong to infect individuals in 37 countries in early 2003.
Alternative Names
Severe Acute Respiratory Syndrome S1; SARS S1; Severe Acute Respiratory Syndrome; SARS
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.